Clinical trials
Trials in Croatia
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1,738 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2000 | 5 |
| 2001 | 12 |
| 2002 | 12 |
| 2003 | 18 |
| 2004 | 32 |
| 2005 | 34 |
| 2006 | 52 |
| 2007 | 60 |
| 2008 | 73 |
| 2009 | 63 |
| 2010 | 60 |
| 2011 | 75 |
| 2012 | 58 |
| 2013 | 66 |
| 2014 | 59 |
| 2015 | 82 |
| 2016 | 69 |
| 2017 | 63 |
| 2018 | 106 |
| 2019 | 97 |
| 2020 | 78 |
| 2021 | 93 |
| 2022 | 80 |
| 2023 | 108 |
| 2024 | 100 |
| 2025 | 89 |
| 2026 | 73 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 1,015 |
| Unknown status | 187 |
| Recruiting | 186 |
| Terminated | 146 |
| Active, not recruiting | 135 |
| Not yet recruiting | 33 |
| Enrolling by invitation | 22 |
| Withdrawn | 10 |
| Approved for marketing | 2 |
| No longer available | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Hoffmann-La Roche | 75 |
| Novo Nordisk A/S | 69 |
| University of Zagreb | 62 |
| Pfizer | 57 |
| AbbVie | 45 |
| Novartis Pharmaceuticals | 44 |
| Sanofi | 43 |
| University of Split, School of Medicine | 43 |
| Eli Lilly and Company | 42 |
| Boehringer Ingelheim | 39 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Diabetes Mellitus, Type 2 | 80 |
| Colitis, Ulcerative | 61 |
| Breast Neoplasms | 50 |
| Crohn Disease | 49 |
| Diabetes Mellitus | 49 |
| Atrial Fibrillation | 45 |
| Schizophrenia | 42 |
| Arthritis, Rheumatoid | 41 |
| Multiple Sclerosis | 38 |
| Carcinoma, Non-Small-Cell Lung | 29 |
Trials
Showing 1 to 25 of 1,738. Each trial links to its page on Pharma Observatory.
1,638 more trials match. See them on Pharma Observatory
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.